BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25978541)

  • 1. Quantitative risk stratification of oral leukoplakia with exfoliative cytology.
    Liu Y; Li J; Liu X; Liu X; Khawar W; Zhang X; Wang F; Chen X; Sun Z
    PLoS One; 2015; 10(5):e0126760. PubMed ID: 25978541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative prediction of oral cancer risk in patients with oral leukoplakia.
    Liu Y; Li Y; Fu Y; Liu T; Liu X; Zhang X; Fu J; Guan X; Chen T; Chen X; Sun Z
    Oncotarget; 2017 Jul; 8(28):46057-46064. PubMed ID: 28545021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEC1: a potential biomarker of malignant transformation in oral leukoplakia.
    Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T
    Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Diagnostic Role of Methyl Green-Pyronin Y Staining in Oral Leukoplakia and Oral Squamous Cell Carcinoma: An Exfoliative Cytology-Based Cytomorphometric Analysis.
    Raman RK; Kamboj M; Narwal A
    Acta Cytol; 2019; 63(5):401-410. PubMed ID: 31112943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
    Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
    J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells are involved in the induction of macrophage phenotypes in oral leukoplakia and squamous cell carcinoma-a preliminary report.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
    J Oral Pathol Med; 2018 Feb; 47(2):136-143. PubMed ID: 29108105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma.
    Sun Y; Liu N; Guan X; Wu H; Sun Z; Zeng H
    Mediators Inflamm; 2016; 2016():5715719. PubMed ID: 28053372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the response of normal oral mucosa, oral leukoplakia, oral squamous cell carcinoma-derived mesenchymal stem cells, and epithelial cells to photodynamic therapy.
    Guo Q; Ji X; Zhang L; Liu X; Wang Y; Liu Z; Jin J; Han Y; Liu H
    J Photochem Photobiol B; 2024 Jun; 255():112907. PubMed ID: 38677259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fourier-transform-infrared-spectroscopy based spectral-biomarker selection towards optimum diagnostic differentiation of oral leukoplakia and cancer.
    Banerjee S; Pal M; Chakrabarty J; Petibois C; Paul RR; Giri A; Chatterjee J
    Anal Bioanal Chem; 2015 Oct; 407(26):7935-43. PubMed ID: 26342309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of ADAM10 in oral squamous cell carcinoma with metastases.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Kulicka P; Danilewicz M
    Pol J Pathol; 2018; 69(1):67-72. PubMed ID: 29895129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laser-capture microdissection and protein extraction for protein fingerprint of OSCC and OLK.
    He H; Sun G; Ping F
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(5):208-13. PubMed ID: 19735007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma.
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
    APMIS; 2018 Sep; 126(9):732-738. PubMed ID: 30160018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of oral exfoliative cytology for the diagnosis of oral squamous dysplasia and carcinoma].
    Navone R; Marsico A; Reale I; Pich A; Broccoletti R; Pentenero M; Gandolfo S
    Minerva Stomatol; 2004 Mar; 53(3):77-86. PubMed ID: 15107778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
    Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
    Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DNA cytometry of exfoliated cells in the diagnosis of oral potential malignant disorders].
    Liu Y; Gao Y; Chen XJ; Hua H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 51(1):16-20. PubMed ID: 30773538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma.
    Wang QM; Huang XY; Guan WQ
    Inflammation; 2022 Jun; 45(3):1023-1038. PubMed ID: 35064378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study.
    Lan Q; Zhang C; Hua H; Hu X
    BMC Oral Health; 2023 Dec; 23(1):1021. PubMed ID: 38115005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exfoliative cytology as a tool for monitoring pre-malignant and malignant lesions based on combined stains and morphometry techniques.
    Gonzalez Segura I; Secchi D; Carrica A; Barello R; Arbelo D; Burgos A; Brunotto M; Zarate AM
    J Oral Pathol Med; 2015 Mar; 44(3):178-84. PubMed ID: 25065639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.